| Ytd | 5.75% | |
| 1y | 6.28% |
| Open | 20.93 | Prev Close | 21.05 | Low | 20.85 | High | 21.18 | Mkt Cap | 1.53B |
| Vol | 1.44M | Avg Vol | 771.14K | EPS | 4.31 | P/E | 4.90 | Forward P/E | 9.57 |
| Beta | 0.33 | Short Ratio | 10.44 | Inst. Own | 109.21% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | 09-08 | Earning | 11-04 | 50-d Avg | 21.22 | 200-d Avg | 21.76 | 1yr Est | 35.00 |
Innoviva (NASDAQ: INVA - Get Free Report) and 60 Degrees Pharmaceuticals (NASDAQ: SXTP - Get Free Re
Baird Financial Group Inc. acquired a new stake in Innoviva, Inc. (NASDAQ: INVA) during the second q
Innoviva, Inc. (NASDAQ: INVA) (âInnovivaâ or the âCompanyâ), a diversified biopharmaceutical
Hsbc Holdings PLC acquired a new position in Innoviva, Inc. (NASDAQ: INVA) during the second quarter
WALTHAM, Mass.--(BUSINESS WIRE)--Innoviva Specialty Therapeutics (IST), a subsidiary of Innoviva, In
Cantor Fitzgerald analyst Steve Seedhouse maintains Innoviva (NASDAQ:INVA) with a Overweight and
Innoviva is a company that is transitioning from a pure royalty-based business to a diversified heal
Innoviva (INVA) came out with quarterly earnings of $0.59 per share, beating the Zacks Consensus Est
Innoviva (NASDAQ:INVA) reported quarterly losses of $(1.14) per share which missed the analyst conse
BURLINGAME, Calif.--(BUSINESS WIRE)--Innoviva, Inc. (NASDAQ: INVA) (“Innoviva” or the “Company”), a
Supernus Pharmaceuticals NASDAQ: SUPN and Indivior Pharmaceuticals announced a proposed all-stock, t
Dimensional Fund Advisors LP grew its holdings in shares of Innoviva, Inc. (NASDAQ: INVA) by 1.7% in
Nortiva Bio, Inc. (âNortivaâ) today announced its launch as a clinical-stage biopharmaceutical c
Company is advancing its proprietary LYNX™ drug delivery platform to develop oral therapies that las
LEXINGTON, Mass.--(BUSINESS WIRE)--Nortiva Bio, Inc. (“Nortiva”) today announced its launch as a cli
Innoviva Specialty Therapeutics, a subsidiary of Innoviva, Inc. (Nasdaq: INVA), today announced that
WALTHAM, Mass.--(BUSINESS WIRE)--Innoviva Specialty Therapeutics, a subsidiary of Innoviva, Inc. (Na
Innoviva, Inc. (INVA) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transc
Innoviva, Inc. (NASDAQ: INVA) (âInnovivaâ or the âCompanyâ), a diversified biopharmaceutical
BURLINGAME, Calif.--(BUSINESS WIRE)--Innoviva, Inc. (NASDAQ: INVA) (“Innoviva” or the “Company”), a
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Innoviva (NASDAQ:INVA) with a Buy a
Innoviva develops respiratory pharmaceuticals through strategic partnerships and royalty agreements
BTIG analyst Julian Harrison maintains Innoviva (NASDAQ:INVA) with a Buy and raises the price tar
Innoviva (INVA) came out with quarterly earnings of $0.44 per share, beating the Zacks Consensus Est
Innoviva (NASDAQ:INVA) reported quarterly earnings of $2.22 per share which beat the analyst consens
BURLINGAME, Calif.--(BUSINESS WIRE)--Innoviva, Inc. (NASDAQ: INVA) (“Innoviva” or the “Company”), a
Merck (MRK) came out with a quarterly loss of $1.28 per share versus the Zacks Consensus Estimate of
On Friday, 497 companies set new 52-week lows.
On Wednesday, 100 stocks hit new 52-week lows.
On Thursday, 1076 companies hit new 52-week lows.
On Tuesday, 507 stocks hit new 52-week lows.
During Friday's session, 574 stocks hit new 52-week lows.
On Tuesday, 126 companies set new 52-week lows.
On Friday, 122 stocks hit new 52-week lows.
On Thursday, 529 companies set new 52-week lows.
On Monday, 273 companies set new 52-week lows.
On Thursday, 108 companies set new 52-week lows.
Before 10 a.m. ET on Wednesday, 77 companies hit new 52-week highs.
During Friday's morning session, 137 companies made new 52-week highs.
On Thursday morning, 159 companies achieved new highs for the year.
Before 10 a.m. ET Wednesday, 138 stocks hit new 52-week highs.
During Tuesday's morning trading, 101 companies set new 52-week highs.
Before 10 a.m. ET on Monday, 201 companies set new 52-week highs.
Thursday's morning session saw 167 companies set new 52-week highs.
Stocks That Hit 52-Week Lows On Wednesday
Stocks That Hit 52-Week Lows On Monday